BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7040505)

  • 1. Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients.
    Levin DL; Roenigk HH; Caro WA; Lyons M
    J Am Acad Dermatol; 1982 Mar; 6(3):328-33. PubMed ID: 7040505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies appearing during PUVA therapy.
    Bruze M; Ljunggren B
    Acta Derm Venereol; 1985; 65(1):31-6. PubMed ID: 2578703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term photochemotherapy: histopathological and immunofluorescence observations in 243 patients.
    Gschnait F; Wolff K; Hönigsmann H; Stingl G; Brenner W; Jaschke E; Konrad K
    Br J Dermatol; 1980 Jul; 103(1):11-22. PubMed ID: 7000141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal connective tissue disease with antinuclear antibodies following PUVA therapy.
    Bruze M; Krook G; Ljunggren B
    Acta Derm Venereol; 1984; 64(2):157-60. PubMed ID: 6203306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal dystrophy and actinic keratoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Follow-up study.
    Abel EA; Cox AJ; Farber EM
    J Am Acad Dermatol; 1982 Sep; 7(3):333-40. PubMed ID: 7130492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibodies during Puva therapy.
    Bjellerup M; Bruze M; Forsgren A; Krook G; Ljunggren B
    Acta Derm Venereol; 1979; 59(1):73-5. PubMed ID: 84474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic alterations of psoralen- and longwave ultraviolet radiation-exposed skin.
    Harrist TJ; Gonzalez E
    Natl Cancer Inst Monogr; 1984 Dec; 66():197-204. PubMed ID: 6531029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term and short-term histopathologic changes in the skin after PUVA therapy.
    Ingraham DM; Bergfeld WF; Bailin PL; Steck WD; Taylor JS; Tomecki KJ
    Cleve Clin Q; 1983; 50(2):133-9. PubMed ID: 6640930
    [No Abstract]   [Full Text] [Related]  

  • 9. Antinuclear antibodies during psoralens plus ultraviolet A (PUVA) therapy--are they worthwhile?
    Picascia DD; Rothe M; Goldberg NS; Roenigk HH
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 1):574-7. PubMed ID: 3493272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
    Berne B; Fischer T; Michaëlsson G; Norén P
    Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
    Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
    Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated superficial actinic porokeratosis: appearance associated with photochemotherapy for psoriasis.
    Hazen PG; Carney JF; Walker AE; Stewart JJ; Engstrom CW
    J Am Acad Dermatol; 1985 Jun; 12(6):1077-8. PubMed ID: 4008702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
    Henseler T; Christophers E
    Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective assessment of photoageing effects using high-frequency ultrasound in PUVA-treated psoriasis patients.
    Sator PG; Schmidt JB; Hönigsmann H
    Br J Dermatol; 2002 Aug; 147(2):291-8. PubMed ID: 12174102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinic degeneration in association with long-term use of PUVA.
    Stern RS; Parrish JA; Fitzpatrick TB; Bleich HL
    J Invest Dermatol; 1985 Feb; 84(2):135-8. PubMed ID: 3968447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies in mice induced by long wave ultraviolet radiation (UVA).
    Bruze M; Forsgren A; Ljunggren B
    Acta Derm Venereol; 1985; 65(1):25-30. PubMed ID: 2578702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous carcinoma in psoriatic patients treated with PUVA.
    Reshad H; Challoner F; Pollock DJ; Baker H
    Br J Dermatol; 1984 Mar; 110(3):299-305. PubMed ID: 6696845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions.
    Ros AM; Wennersten G; Lagerholm B
    Acta Derm Venereol; 1983; 63(3):215-21. PubMed ID: 6192634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis.
    Morison WL; Wimberly J; Parrish JA; Bloch KJ
    Br J Dermatol; 1983 Apr; 108(4):445-50. PubMed ID: 6838768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective accumulation of lipid within melanocytes during photochemotherapy (PUVA) of psoriasis.
    Schuler G; Hönigsmann H; Jaschke E; Wolff K
    Br J Dermatol; 1982 Aug; 107(2):173-81. PubMed ID: 7104216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.